50shadesofsun.com
Ocrevus: Counting Down to Expected FDA Approval
There is now less than a month until the U.S. Food and Drug Administration (FDA) is expected to approve Ocrevus, generic name ocrelizumab, for use as a therapy for multiple sclerosis. Clinical tria…